COMPASS Pathways Plc - American Depository Shares (NQ:CMPS)

13.10 +0.04 (+0.31%)

Streaming Delayed Price Updated: 12:16 PM EDT, Sep 28, 2026 Add to My Watchlist

Price and Volume

Volume	671,440
Open	13.10
Bid (Size)	13.08 (400)
Ask (Size)	13.10 (200)
Prev. Close	13.06
Today's Range	12.82 - 13.27
52wk Range	4.880 - 15.87
Shares Outstanding	41,695,335
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Compass Pathways Targets Q4 COMP360 NDA Completion, Eyes 2027 Launch ↗

September 24, 2026

Compass Pathways (NASDAQ:CMPS) executives said the company remains on track to complete its rolling New Drug Application submission for COMP360 in the fourth quarter, while preparing commercial...

Via MarketBeat

Compass Pathways Targets 2027 COMP360 Launch After Positive Phase III Depression Data ↗

September 22, 2026

Compass Pathways (NASDAQ:CMPS) said it remains on track to complete its rolling New Drug Application submission for COMP360 in the fourth quarter of 2026, following positive Phase III studies of its...

Via MarketBeat

Performance

YTD	+100.0%	+100.0%
1 Month	-4.6%	-4.6%
3 Month	-13.1%	-13.1%
6 Month	+150.0%	+150.0%
1 Year	+123.2%	+123.2%

More News

Compass Pathways Eyes 2027 COMP360 Launch as FDA Review Advances ↗

September 22, 2026

Via MarketBeat

Compass Pathways (NASDAQ:CMPS) Shares Plunge 42% After Q2 Report Despite Narrower-Than-Expected Loss ↗

August 05, 2026

Via Chartmill

Compass Pathways Eyes 2027 COMP360 Launch as FDA Filing Nears ↗

September 22, 2026

Via MarketBeat

Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026

September 16, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026

September 15, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Announces U.S. Grant Program Recipients for the Development of Post-Approval COMP360 Provider Training

September 10, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Participate in Investor Conferences the Week of September 14th

September 10, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year

September 09, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026

September 08, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 03, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Recognized as a 2026 Fierce 50 Breakthrough Honoree

September 02, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Participate in 2026 Cantor Global Healthcare Conference on September 9, 2026

September 01, 2026

From Compass Pathfinder Limited

Via Business Wire

COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript ↗

August 12, 2026

Via The Motley Fool

Compass Pathways Targets 2027 COMP360 Launch as FDA Filing Advances ↗

August 12, 2026

Via MarketBeat

Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026

August 06, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin

August 06, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 05, 2026

From Compass Pathfinder Limited

Via Business Wire

A CEO With a Proven Track Record of Success in Growing and Scaling Biopharmaceutical Companies Just Appointed CEO at a Clinical-Stage Biotech, Months Before Its Pivotal Phase 3 Readout

August 05, 2026

From USA News Group

Via GlobeNewswire

Compass Pathways Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

August 05, 2026

From Compass Pathfinder Limited

Via Business Wire

Compass Pathways to Announce Second Quarter and First Half 2026 Financial Results on August 5, 2026

July 29, 2026

From Compass Pathfinder Limited

Via Business Wire

Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. ↗

July 29, 2026

Via The Motley Fool

Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. ↗

July 23, 2026

Via The Motley Fool

Frequently Asked Questions

Is COMPASS Pathways Plc - American Depository Shares publicly traded?

Yes, COMPASS Pathways Plc - American Depository Shares is publicly traded.

What exchange does COMPASS Pathways Plc - American Depository Shares trade on?

COMPASS Pathways Plc - American Depository Shares trades on the Nasdaq Stock Market

What is the ticker symbol for COMPASS Pathways Plc - American Depository Shares?

The ticker symbol for COMPASS Pathways Plc - American Depository Shares is CMPS on the Nasdaq Stock Market

What is the current price of COMPASS Pathways Plc - American Depository Shares?

The current price of COMPASS Pathways Plc - American Depository Shares is 13.10

When was COMPASS Pathways Plc - American Depository Shares last traded?

The last trade of COMPASS Pathways Plc - American Depository Shares was at 09/28/26 12:16 PM ET

What is the market capitalization of COMPASS Pathways Plc - American Depository Shares?

The market capitalization of COMPASS Pathways Plc - American Depository Shares is 546.21M

How many shares of COMPASS Pathways Plc - American Depository Shares are outstanding?

COMPASS Pathways Plc - American Depository Shares has 546M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.